Brown Capital Management LLC Meridian Bioscience Inc Transaction History

Brown Capital Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 08, 2020	SELL	$5.57 - $11.5 $234,591 - $484,345	-42,117 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$7.9 - $10.14 $19.2 Million - $24.6 Million	-2,430,112 Reduced 98.3%	42,117 $411,000
Q3 2019 Nov 13, 2019	SELL	$9.17 - $12.01 $10.3 Million - $13.5 Million	-1,127,563 Reduced 31.32%	2,472,229 $23.5 Million
Q2 2019 Aug 13, 2019	SELL	$10.88 - $17.6 $274,371 - $443,836	-25,218 Reduced 0.7%	3,599,792 $42.8 Million
Q1 2019 May 15, 2019	SELL	$15.51 - $17.61 $506,479 - $575,054	-32,655 Reduced 0.89%	3,625,010 $63.8 Million
Q4 2018 Feb 14, 2019	SELL	$14.52 - $19.72 $90,808 - $123,328	-6,254 Reduced 0.17%	3,657,665 $63.5 Million
Q2 2018 Aug 14, 2018	SELL	$13.8 - $16.8 $4.75 Million - $5.78 Million	-344,320 Reduced 8.59%	3,663,919 $58.3 Million
Q1 2018 May 15, 2018	SELL	$13.8 - $16.2 $9.07 Million - $10.6 Million	-656,904 Reduced 14.08%	4,008,239 $56.9 Million
Q4 2017 Feb 14, 2018	SELL	$13.55 - $15.8 $11.2 Million - $13.1 Million	-828,323 Reduced 15.08%	4,665,143 $65.3 Million
Q3 2017 Nov 14, 2017	BUY	$13.45 - $14.35 $73.9 Million - $78.8 Million	5,493,466	5,493,466 $78.6 Million

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Brown Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Brown Capital Management LLC with notifications on news.